In this exclusive video ahead of the upcoming American Society of Hematology annual meeting, Vijay G. Sankaran, MD, PhD, of Boston Children's Hospital, previews a multidisciplinary session on how ...
Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
Drug shortages are a clear and growing challenge. Prominent shortages included oncology medications and supportive care products essential for the care of patients with cancer. Oncology drug shortages ...
A friendly debate held at the European Hematology Association 2023 Congress focused on the potential for real-world data to improve the generalizability of clinical trial results but also acknowledged ...
The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the ...
The new CTO-H provides the largest, longest and deepest view of hematological diseases ever created — establishing a new standard for clinical research Starting in 2023, NeoGenomics and ConcertAI ...
Healio will present its fifth annual Disruptive Innovators Awards for oncology/hematology this spring.Individuals who have ...
A pair of assessments conducted by the American Society of Hematology (ASH) have helped identify roadblocks to improving diversity in clinical trials and elucidated the strategies ASH members use to ...
Patient centricity is too frequently used as a buzzword in a grand vision statement or keynote address — so often that it can lose its meaning. For me, it is more than that. It is a credo that guides ...
Our fellowship program is dedicated to advancing the art and science of medicine through a rich and diverse educational experience at top-flight academic medical centers. The program is a ...
Director, Sickle Cell Disease and Iron Overload Program, Fred Hutch Assistant Professor, Division of Hematology and Oncology, University of Washington School of Medicine Personalized care is very ...
CAMBRIDGE, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results